Skip to main content
HR
NYSE Real Estate & Construction

Healthcare Realty Trust Reports Strong 2025 Results, Balance Sheet Improvements, and $50M Share Buyback

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: REIT Stocks · Real Estate
Sentiment info
Positive
Importance info
8
Price
$18.45
Mkt Cap
$6.475B
52W Low
$14.09
52W High
$18.97
52W Position info
31% above low
Off High info
2.7% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

HR sits 31% above its 52-week low of $14.09.

Summary

Healthcare Realty Trust published a business update presentation detailing strong 2025 financial performance, significant balance sheet improvements, and the execution of a $50 million share repurchase program.


Key Events · Financing and Capital Events · HR

  • Strong 2025 Financial Performance

    The company reported a Normalized FFO per share of $1.61 (+3% YoY), 92.1% Same Store Occupancy (+103 bps), and 4.8% Same Store Cash NOI Growth (+1.9%), meeting or exceeding initial 2025 guidance.

  • Significant Balance Sheet Improvement

    Healthcare Realty Trust reduced its Net Debt to Adjusted EBITDA to 5.4x (down 0.7x YoY), repaid $900 million in Term Loans and Senior Notes, and extended debt maturities, resulting in $1.4 billion of liquidity and affirmed BBB/Baa2 credit ratings.

  • Execution of Share Repurchase Program

    The company repurchased $50 million of its shares in January 2026, utilizing a portion of the $500 million authorization announced in its recent 10-K filing, signaling management's confidence in the stock's value despite trading near 52-week highs.

  • Progress on Strategic Plan

    The update highlighted rapid execution of the 'Healthcare Realty 2.0 Strategic Plan,' including $1.7 billion in dispositions, $10 million in G&A savings, and improved leasing outcomes, leading to a more focused and higher-quality portfolio.


Analysis · HR · Real Estate & Construction

This comprehensive business update highlights Healthcare Realty Trust's successful execution of its strategic plan, leading to strong financial performance in 2025 and a significantly improved balance sheet. The company's ability to reduce debt by $900 million and achieve a Net Debt to Adjusted EBITDA of 5.4x demonstrates robust financial management. The execution of a $50 million share repurchase in January 2026, part of a larger $500 million authorization, signals strong management confidence in the company's valuation, especially as the stock trades near its 52-week high. This update reinforces a positive outlook for investors, indicating operational efficiency and a commitment to shareholder value.

How filings like this one have moved

In the 30 days to Oct 1, 2026, 36% of the 1040 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.56%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, HR was trading at $18.45 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $6.5B. The 52-week trading range was $14.09 to $18.97. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

HR - Latest Insights

HR
Aug 03, 2026, 7:33 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $21.75
Real-time Price: $17.75 info
Change: -$4.00 (-18%) info
Market Cap: $6.08B info
HR
Jul 31, 2026, 5:26 PM EDT
Filing Type: S-3
Importance Score:
7
Price at Filing: $21.01
Real-time Price: $17.75 info
Change: -$3.26 (-16%) info
Market Cap: $6.08B info
HR
Jul 31, 2026, 3:15 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $21.18
Real-time Price: $17.75 info
Change: -$3.43 (-16%) info
Market Cap: $6.08B info
HR
Jul 30, 2026, 4:07 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $21.18
Real-time Price: $17.75 info
Change: -$3.43 (-16%) info
Market Cap: $6.08B info
HR
Jul 30, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $21.18
Real-time Price: $17.75 info
Change: -$3.43 (-16%) info
Market Cap: $6.08B info